NIH-funded research R03 grant

Genetic clues to mouth muscles development in SMA

Official title: Genetic characterization of MesV sensory cells in normal development and in the neurodegenerative disease spinal muscular atrophy

Funded at Columbia University Health Sciences · NIH-11356582 · Data updated 2026-11-12

A small NIH grant studies how nerve cells controlling jaw movements develop normally and how this process goes wrong in spinal muscular atrophy (SMA).

More Spinal Muscular Atrophy research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2026
Project endMay 31, 2028
Funding year2026
Award (this year)$329,000
NIH project number1R03DE036052-01
Project IDNIH-11356582 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with or at risk for SMA or related orofacial motor vulnerabilities, particularly adults or young adults who can contribute samples or participate in related observational studies.

Less likely to help

Individuals without SMA or related orofacial motor issues may not directly benefit from this study.

What this research studies

This project looks at how the facial muscles and their sensory nerves mature from infancy to early childhood, focusing on the masseter muscle used for chewing. It explores whether early electrical connections between nerve cells and sensors help the transition from sucking to chewing, and how these connections may be disrupted in SMA. The work combines genetic and developmental approaches to understand normal patterns and disease-related changes in a specific brainstem region called MesV. The findings could reveal targets for therapies that protect or improve feeding-related movements in people with SMA. The study is conducted using human-relevant development timelines and aims to translate basic insights into future patient-focused options.

Why it matters

Potential benefit: If successful, the research could lead to new strategies to preserve or restore safe eating and chewing in people with SMA.

How similar studies have gone: Past research has shown that sensory-mmotor circuits can mature in predictable sequences, but this project investigates a specific developmental mechanism with potential novelty.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Florez Paz, Danny Mauricio — Columbia University Health Sciences
  • Study coordinator: Florez Paz, Danny Mauricio

Related research

Other NIH-funded projects on the same topics.

  • Therapeutic gene editing for spinal muscular atrophy

    A patient-facing look at a project that aims to test a gene-editing approach to help children with spinal muscular atrophy.

    NIH research Jackson Laboratory · Bar Harbor, United States · NIH-11326247

  • SMN-independent approaches for spinal muscular atrophy

    This project looks for new treatments for people with spinal muscular atrophy that work without relying only on restoring the SMN protein.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11307153

  • How RNA problems cause nerve and muscle damage in spinal muscular atrophy

    This project looks at how RNA-related problems lead to nerve and muscle damage in people with spinal muscular atrophy to help find better treatment targets.

    NIH research Columbia University Health Sciences · New York, United States · NIH-11285173

  • Investigating speech development in children with spinal muscular atrophy after new therapies

    This study is looking at how new treatments for spinal muscular atrophy (SMA) can help improve speech and communication skills in children and young adults aged 2 to 21, by comparing their speech abilities to what’s expected for their age.

    NIH research University of Wisconsin-Madison · Madison, United States · NIH-11242987

  • Correcting Genetic Errors for Spinal Muscular Atrophy

    This research looks for new ways to fix the genetic problem that causes Spinal Muscular Atrophy, a condition that weakens muscles.

    NIH research Ohio State University · Columbus, UNITED STATES · NIH-11123252

  • Gene editing to treat spinal muscular atrophy

    This study is working on a new gene editing treatment for spinal muscular atrophy (SMA) to see how well it can help improve muscle strength and overall health, especially for infants affected by this condition.

    NIH research Jackson Laboratory · Bar Harbor, United States · NIH-11089352

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.